Feasibility of the COMFORT (COmplex Symptom Management Intervention FOR adulTs With Advanced Kidney Disease) Intervention for Adults With Advanced Kidney Disease and Their Informal Caregivers (COMFORT)
Feasibility of the COMFORT Intervention: A Randomised Feasibility Study of a Tailored Nurse-Led Symptom Management Intervention for Adults With Advanced Kidney Disease and Their Informal Caregivers
The purpose of this randomized feasibility study is to examine whether the COMFORT intervention is feasible and acceptable for adults with advanced kidney disease and their informal caregivers.
People with advanced kidney disease often experience several symptoms, such as fatigue, itching, pain, and sleep-related problems. These symptoms can affect daily life and quality of life and may also place a burden on family members and other informal caregivers. The COMFORT intervention is a nurse-led programme designed to help patients and their informal caregivers recognise and manage symptoms.
A total of 56 adults with advanced kidney disease will be randomly assigned to one of two groups. One group will receive usual care. The other group will receive usual care plus the COMFORT intervention over approximately 3 months. The intervention includes systematic assessment of symptoms, a symptom management decision-support tool, shared decision-making, support for self-management, and involvement and support of informal caregivers. It is delivered by trained nephrology nurses through two structured consultations and one follow-up telephone consultation.
The study will examine whether patients can be successfully recruited and retained, whether the intervention can be delivered as planned, whether patients, informal caregivers, and nurses find the intervention acceptable, and whether the study procedures and questionnaires are suitable for use in a future larger trial. The study is not designed to determine whether the COMFORT intervention is clinically effective.
調査の概要
詳細な説明
Adults with advanced kidney disease may experience a substantial burden of physical and psychosocial symptoms, including fatigue, drowsiness, pruritus, pain, and restless legs. Multiple symptoms frequently occur at the same time and can negatively affect daily functioning, quality of life, and participation in everyday activities. Informal caregivers may also experience considerable burden, emotional strain, and uncertainty about how best to support the person with advanced kidney disease.
Despite the high symptom burden, systematic symptom assessment and management are not consistently integrated into routine kidney care. Symptom management strategies may focus on individual symptoms rather than addressing multiple co-occurring symptoms and the broader needs and preferences of patients and their informal caregivers. Patients and caregivers may therefore benefit from a more structured approach that supports symptom recognition and management, shared decision-making, self-management, and caregiver involvement.
The COMFORT Nursing Programme was established in 2023 to address these challenges. The programme has developed a structured, theory-informed, nurse-led intervention for symptom management in adults with advanced kidney disease. The COMFORT intervention comprises four core components: symptom management, shared decision-making, self-management support, and caregiver support.
The intervention combines systematic symptom assessment using the Integrated Palliative care Outcome Scale-Renal (IPOS-Renal) with an evidence-based symptom management decision-support tool. Based on the symptoms, needs, and preferences identified by the participant, trained nephrology nurses support participants in prioritising symptoms, considering relevant symptom management strategies, participating in shared decisions, and strengthening their ability to manage symptoms in everyday life. Informal caregivers are involved and supported as part of the intervention.
In this randomized feasibility study, adults with advanced kidney disease are allocated in a 1:1 ratio to usual care or usual care supplemented with the COMFORT intervention. The intervention is delivered over approximately 3 months and comprises two structured nurse-led consultations and one follow-up telephone consultation.
The primary purpose of the study is to evaluate the feasibility and acceptability of the COMFORT intervention and the procedures required for a future definitive randomised controlled trial. The study will therefore evaluate recruitment and retention, intervention fidelity, acceptability among participants and nephrology nurses, completion and suitability of proposed outcome measures, and the feasibility of study procedures. Patient-reported and caregiver-reported measures will also be collected to evaluate their suitability for a future trial.
The feasibility findings will be used to refine the COMFORT intervention and study procedures and to inform the design and conduct of a future multicentre randomised controlled trial evaluating the effectiveness of the COMFORT intervention.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Jeanette Finderup
- 電話番号：004578452525
- メール：jeajee@rm.dk
研究場所
-
-
Capital Region
-
Copenhagen、Capital Region、デンマーク、2100
- Rigshospitalet, Copenhagen University Hospital
-
コンタクト：
- Anne Sophie Mathiesen
- 電話番号：004527908669
- メール：Anne.Sophie.Mathiesen@regionh.dk
-
コンタクト：
- Nina Schjerning
-
-
Central Jutland
-
Aarhus、Central Jutland、デンマーク、8200
- Aarhus University Hospital
-
コンタクト：
- Jeanette Finderup
- 電話番号：004578452525
- メール：jeajee@rm.dk
-
副調査官：
- Signe Damsgaard
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Patients:
- Age 18 years or older
- Advanced kidney disease
- At least one symptom with a score ≥2 on the Integrated Palliative care Outcome Scale-Renal (IPOS-Renal)
- Receiving haemodialysis, peritoneal dialysis, conservative kidney management, or predialysis care
- Able to provide informed consent
Informal caregivers:
- Age 18 years or older
- Identified by a participating patient as an informal caregiver or close relative
- Able to provide informed consent
Exclusion Criteria:
Patients:
- Unable to speak or read Danish
- Unable to provide informed consent
- Unable to complete study questionnaires
- Severe psychiatric disorder
Informal caregivers:
- Unable to speak Danish
- Unable to complete study questionnaires
- Unable to provide informed consent
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Usual Care
Participants allocated to the control group receive usual kidney care according to standard clinical practice at the participating nephrology departments during the 3 months study period.
|
Participants receive usual kidney care according to standard clinical practice at the participating nephrology departments during the 12-week study period.
Participants in this arm do not receive the COMFORT intervention.
|
|
実験的：COMFORT Intervention
Participants allocated to the intervention group receive usual kidney care supplemented with the COMFORT intervention during the 3 months study period.
The COMFORT intervention is a tailored, nurse-led symptom management intervention that includes systematic symptom assessment, a symptom management decision-support tool, shared decision-making, self-management support, and involvement and support of informal caregivers.
The intervention is delivered by trained nephrology nurses through two structured consultations and one follow-up telephone consultation.
|
The COMFORT intervention is a tailored, nurse-led symptom management intervention for adults with advanced kidney disease and their informal caregivers. It includes systematic symptom assessment using the Integrated Palliative care Outcome Scale-Renal (IPOS-Renal), an evidence-based symptom management decision-support tool, shared decision-making, self-management support, and caregiver involvement and support. The intervention is delivered by trained nephrology nurses over 12 weeks through two structured consultations and one follow-up telephone consultation, in addition to usual kidney care. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Recruitment Rate
時間枠：Baseline and 3 months
|
Percentage of eligible patients approached for participation who provide informed consent and are enrolled in the feasibility study.
The recruitment rate will be calculated as the number of enrolled patients divided by the number of eligible patients approached, multiplied by 100.
|
Baseline and 3 months
|
|
Participant Retention Rate at 3 Months
時間枠：3 months after enrolment
|
Percentage of enrolled patients who remain in the feasibility study and complete the 3-month follow-up assessment.
The retention rate will be calculated as the number of enrolled patients completing the 3-month follow-up divided by the total number of enrolled patients, multiplied by 100.
|
3 months after enrolment
|
|
Adherence to the COMFORT Intervention
時間枠：Baseline and 3 months
|
Percentage of planned COMFORT intervention sessions attended by participants allocated to the intervention group.
Adherence will be calculated as the number of intervention sessions attended divided by the number of planned intervention sessions, multiplied by 100.
Scores range from 0% to 100%, with higher percentages indicating greater adherence.
|
Baseline and 3 months
|
|
Fidelity to the COMFORT Intervention
時間枠：Baseline and 3 months
|
Percentage of prespecified COMFORT intervention components delivered as planned, assessed using session logs completed by the nephrology nurses delivering the intervention.
Fidelity will be calculated as the number of intervention components delivered as planned divided by the number of applicable prespecified components, multiplied by 100.
Scores range from 0% to 100%, with higher percentages indicating greater intervention fidelity.
|
Baseline and 3 months
|
|
Completeness of Questionnaire Data
時間枠：Baseline and 3 months
|
Percentage of expected questionnaire data that are completed at the planned assessment time points.
Data completeness will be calculated as the number of completed questionnaire data fields divided by the total number of expected questionnaire data fields, multiplied by 100.
Scores range from 0% to 100%, with higher percentages indicating greater data completeness.
|
Baseline and 3 months
|
|
Acceptability of the COMFORT Intervention Assessed by Qualitative Interviews
時間枠：At 3 months
|
Acceptability of the COMFORT intervention will be explored through qualitative interviews with participating patients, informal caregivers, and nephrology nurses.
Interview data will be analysed qualitatively to identify themes specifically related to experiences of and acceptability of the intervention.
|
At 3 months
|
|
Perceived Relevance of the COMFORT Intervention Assessed by Qualitative Interviews
時間枠：At 3 months
|
Perceived relevance of the COMFORT intervention will be explored through qualitative interviews with participating patients and informal caregivers.
Interview data will be analysed qualitatively to identify themes specifically related to the perceived relevance of the intervention.
|
At 3 months
|
|
Perceived Feasibility of the COMFORT Intervention Assessed by Qualitative Interviews
時間枠：At 3 months
|
Perceived feasibility of the COMFORT intervention will be explored through qualitative interviews with participating patients, informal caregivers, and nephrology nurses.
Interview data will be analysed qualitatively to identify themes specifically related to the practical feasibility of the intervention.
|
At 3 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change From Baseline in Symptom Burden Assessed With the Integrated Palliative care Outcome Scale-Renal at 3 Months
時間枠：Baseline and 3 months
|
Symptom burden will be assessed using the Integrated Palliative care Outcome Scale-Renal (IPOS-Renal).
The IPOS-Renal total score ranges from 0 to 90, with higher scores indicating greater symptom burden and other health-related concerns.
The outcome will be the change in total score from baseline to 3 months.
|
Baseline and 3 months
|
|
Change From Baseline in EuroQol 5-Dimension 3-Level Index Score at 3 Months
時間枠：Baseline and 3 months.
|
Health-related quality of life will be assessed using the EuroQol 5-Dimension 3-Level (EQ-5D-3L) questionnaire.
Health states will be converted to an EQ-5D-3L index score using the Danish time trade-off value set.
Index scores range from -0.624 to 1.000, with higher scores indicating better health-related quality of life.
The outcome will be the change in index score from baseline to 3 months.
|
Baseline and 3 months.
|
|
Change From Baseline in Fatigue Severity Scale Score at 3 Months
時間枠：Baseline and 3 months.
|
Fatigue will be assessed using the 9-item Fatigue Severity Scale (FSS).
The total score ranges from 9 to 63, with higher scores indicating greater fatigue severity.
The outcome will be the change in total score from baseline to 3 months.
|
Baseline and 3 months.
|
|
Change From Baseline in Life Participation Assessed With Standardised Outcomes in Nephrology-Life Participation at 3 Months
時間枠：Baseline and 3 months.
|
Life participation will be assessed using the Standardised Outcomes in Nephrology-Life Participation (SONG-LP) instrument.
The overall score ranges from 0 to 4 and is calculated as the mean of the available item scores.
Higher scores indicate better life participation.
The outcome will be the change in overall score from baseline to 3 months.
|
Baseline and 3 months.
|
|
Change From Baseline in Shared Decision-Making Assessed With the Patient Experience of Shared Decision Making Questionnaire at 3 Months
時間枠：Baseline and 3 months
|
Shared decision-making will be assessed using the Danish version of the 10-item Patient Experience of Shared Decision Making Questionnaire (SHARED-10).
Each item is rated on a 5-point Likert scale from strongly disagree to strongly agree, with higher item scores indicating greater perceived shared decision-making.
The instrument assesses three domains: healthcare professional contribution (items 1-4), patient contribution (items 5-7), and shared agreement in the decision (items 8-10).
Change from baseline to 3 months will be assessed.
|
Baseline and 3 months
|
|
Change From Baseline in Self-Management Assessed With the Chronic Kidney Disease Self-Management Questionnaire at 3 Months
時間枠：Baseline and 3 months
|
Self-management will be assessed using the 17-item short version of the Chronic Kidney Disease Self-Management questionnaire (CKD-SM-17).
Each item is rated on a 4-point response scale from never to always.
Item scores range from 1 to 4, giving a total score ranging from 17 to 68, with higher scores indicating greater engagement in self-management behaviours.
The outcome will be the change in total score from baseline to 3 months.
|
Baseline and 3 months
|
|
Change From Baseline in Caregiver Burden Assessed With the 12-Item Zarit Burden Interview at 3 Months
時間枠：Baseline to 3 months
|
Caregiver burden will be assessed among participating informal caregivers using the 12-item Zarit Burden Interview (ZBI-12).
The total score ranges from 0 to 48, with higher scores indicating greater caregiver burden.
The outcome will be the change in total score from baseline to 3 months.
|
Baseline to 3 months
|
協力者と研究者
スポンサー
出版物と役立つリンク
便利なリンク
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- COMFORT-FS-2026
- 0082713 (その他の助成金/資金番号：Novo Nordic Foundation)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。